| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President &CEO
1 company
Luthringer Remy is a CEO at NERV. Recent filings cover 0 purchases and 8 sales. Those positions are worth an estimated $259K at current prices.
Luthringer Remy's largest disclosed position is in NERV as CEO, worth about $259K. The recent filings there lean toward selling, a net 70,185 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | NERV Minerva Neurosciences, Inc. | CEO | Sell | 27,394 | $3.84 | $105,139.21 | -28.4% | +107.2% | -47.7% | |
| Dec 16, 2020 | NERV Minerva Neurosciences, Inc. | CEO | Sale+OE | 1,300 | $2.64 | $3,432.00 | -1.9% | - | - | |
| Dec 17, 2019 | NERV Minerva Neurosciences, Inc. | CEO | Sale+OE | 2,412 | $7.10 | $17,125.20 | -4.7% | - | - | |
| Dec 17, 2018 | NERV Minerva Neurosciences, Inc. | CEO | Sale+OE | 2,604 | $7.46 | $19,425.84 | -7.4% | - | - | |
| Dec 14, 2017 | NERV Minerva Neurosciences, Inc. | CEO | Sale+OE | 2,194 | $5.85 | $12,834.90 | -11.7% | - | - | |
| Feb 6, 2017 | NERV Minerva Neurosciences, Inc. | President &CEO | Sale+OE | 34,281 | $11.02 | $377,732.92 | - | - | - |